125997-11-7Relevant academic research and scientific papers
CYCLIC PYRIMIDIN-4-CARBOXAMIDES AS CCR2 RECEPTOR ANTAGONISTS FOR TREATMENT OF INFLAMMATION, ASTHMA AND COPD
-
Page/Page column 110, (2010/08/05)
The present invention relates to novel antagonists for CCR2 (CC chemokine receptor 2) and their use for providing medicaments for treating conditions and diseases, especially pulmonary diseases like asthma and COPD. Formula (I), wherein A is selected from among a single bond, =CH-, -CH2-, -O-, -S-, and -NH-; wherein n is 1, 2 or 3; wherein Z is C or N, the other variables are as defined in the claims, as well as in form of their acid addition salts with pharmacologically acceptable acids.
Mechanism of the palladium dichloride catalyzed cope rearrangement of acyclic dienes. A substituent effect study
Overman, Larry E.,Renaldo, Alfred F.
, p. 3945 - 3949 (2007/10/02)
The PdCl2-catalyzed Cope rearrangement of eight 2-aryl-1,5-hexadienes was studied. No simple substituent effect relationship was found, since the catalyzed-rearrangement rate was decreased by introducing both electron-withdrawing and electron-d
